Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 5 | 2021 | 918 | 1.620 |
Why?
|
| Silicone Oils | 2 | 2021 | 10 | 1.460 |
Why?
|
| Vitreous Body | 1 | 2021 | 10 | 0.750 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 12 | 0.720 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2018 | 5 | 0.650 |
Why?
|
| Practice Management, Medical | 1 | 2018 | 8 | 0.640 |
Why?
|
| Medical Oncology | 1 | 2019 | 86 | 0.640 |
Why?
|
| Cerebrospinal Fluid | 1 | 2018 | 17 | 0.630 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 98 | 0.630 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 102 | 0.630 |
Why?
|
| Orbit | 1 | 2018 | 19 | 0.620 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 458 | 0.520 |
Why?
|
| Dermoid Cyst | 1 | 2015 | 3 | 0.510 |
Why?
|
| Ovary | 1 | 2015 | 58 | 0.490 |
Why?
|
| Malaria | 2 | 2004 | 11 | 0.480 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 1328 | 0.450 |
Why?
|
| Brain | 1 | 2020 | 951 | 0.430 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 608 | 0.360 |
Why?
|
| Humans | 19 | 2021 | 32005 | 0.330 |
Why?
|
| Neoplasms | 1 | 2015 | 726 | 0.310 |
Why?
|
| Male | 12 | 2021 | 19165 | 0.270 |
Why?
|
| Mass Spectrometry | 3 | 2015 | 102 | 0.270 |
Why?
|
| Middle Aged | 8 | 2021 | 11817 | 0.270 |
Why?
|
| Anopheles | 1 | 2004 | 1 | 0.240 |
Why?
|
| Insect Vectors | 1 | 2004 | 4 | 0.240 |
Why?
|
| Retrospective Studies | 4 | 2021 | 3509 | 0.230 |
Why?
|
| Software | 3 | 2018 | 123 | 0.230 |
Why?
|
| Poverty | 1 | 2004 | 111 | 0.230 |
Why?
|
| Young Adult | 6 | 2021 | 2636 | 0.220 |
Why?
|
| Proteomics | 2 | 2015 | 94 | 0.200 |
Why?
|
| Infant, Newborn | 3 | 2021 | 671 | 0.190 |
Why?
|
| Peptides | 3 | 2006 | 120 | 0.190 |
Why?
|
| Ear Diseases | 1 | 2021 | 7 | 0.190 |
Why?
|
| Female | 8 | 2021 | 19959 | 0.190 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 762 | 0.190 |
Why?
|
| Cervical Vertebrae | 1 | 2021 | 44 | 0.180 |
Why?
|
| Dengue | 1 | 2020 | 5 | 0.180 |
Why?
|
| Dengue Vaccines | 1 | 2020 | 3 | 0.180 |
Why?
|
| Immunization, Secondary | 1 | 2020 | 11 | 0.180 |
Why?
|
| Corpus Callosum | 1 | 2020 | 18 | 0.180 |
Why?
|
| Retinal Detachment | 1 | 2020 | 9 | 0.180 |
Why?
|
| Treatment Outcome | 2 | 2019 | 3306 | 0.170 |
Why?
|
| Hemorrhage | 1 | 2020 | 100 | 0.170 |
Why?
|
| Ultrasonography | 2 | 2015 | 379 | 0.170 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 3990 | 0.170 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2020 | 112 | 0.170 |
Why?
|
| Workflow | 1 | 2018 | 21 | 0.160 |
Why?
|
| Adult | 7 | 2021 | 9345 | 0.160 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 38 | 0.160 |
Why?
|
| Infant | 2 | 2021 | 1061 | 0.160 |
Why?
|
| Animals | 11 | 2015 | 7541 | 0.160 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 517 | 0.160 |
Why?
|
| Hypoglycemic Agents | 2 | 2018 | 181 | 0.150 |
Why?
|
| Child, Preschool | 2 | 2021 | 1269 | 0.150 |
Why?
|
| Telemedicine | 1 | 2018 | 102 | 0.140 |
Why?
|
| Decision Making | 1 | 2018 | 195 | 0.140 |
Why?
|
| Maximum Tolerated Dose | 1 | 2015 | 62 | 0.130 |
Why?
|
| Nerve Growth Factors | 1 | 2015 | 16 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 633 | 0.130 |
Why?
|
| Clinical Competence | 1 | 2018 | 333 | 0.130 |
Why?
|
| Child | 2 | 2021 | 2438 | 0.130 |
Why?
|
| Age Factors | 1 | 2018 | 1188 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 120 | 0.120 |
Why?
|
| Proteins | 2 | 2006 | 144 | 0.120 |
Why?
|
| C-Reactive Protein | 1 | 2015 | 238 | 0.120 |
Why?
|
| Gene Expression Profiling | 2 | 2007 | 322 | 0.120 |
Why?
|
| Thiazolidinediones | 2 | 2006 | 47 | 0.120 |
Why?
|
| Climate Change | 1 | 2013 | 4 | 0.120 |
Why?
|
| Carbon | 1 | 2013 | 12 | 0.120 |
Why?
|
| Social Responsibility | 1 | 2013 | 12 | 0.110 |
Why?
|
| Aged | 4 | 2021 | 10301 | 0.110 |
Why?
|
| Parietal Bone | 1 | 2012 | 12 | 0.100 |
Why?
|
| Skull Fractures | 1 | 2012 | 17 | 0.100 |
Why?
|
| Alzheimer Disease | 1 | 2015 | 327 | 0.100 |
Why?
|
| Prognosis | 1 | 2015 | 1497 | 0.100 |
Why?
|
| Intensive Care Units | 1 | 2012 | 110 | 0.100 |
Why?
|
| Sepsis | 1 | 2012 | 161 | 0.090 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 2010 | 4 | 0.090 |
Why?
|
| Algorithms | 4 | 2010 | 495 | 0.090 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2008 | 2 | 0.080 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2008 | 3 | 0.080 |
Why?
|
| Substance P | 1 | 2008 | 20 | 0.080 |
Why?
|
| Kidney Pelvis | 1 | 2008 | 17 | 0.080 |
Why?
|
| TRPV Cation Channels | 1 | 2008 | 22 | 0.080 |
Why?
|
| Neurons, Afferent | 1 | 2008 | 56 | 0.070 |
Why?
|
| Models, Biological | 2 | 2007 | 392 | 0.070 |
Why?
|
| Arteries | 1 | 2008 | 67 | 0.070 |
Why?
|
| Ganglia, Spinal | 1 | 2008 | 65 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 72 | 0.070 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2006 | 4 | 0.070 |
Why?
|
| Complex Mixtures | 1 | 2006 | 3 | 0.070 |
Why?
|
| Proteome | 1 | 2007 | 39 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 226 | 0.070 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 27 | 0.070 |
Why?
|
| Sodium Channels | 1 | 2006 | 15 | 0.070 |
Why?
|
| Ion Channel Gating | 1 | 2006 | 20 | 0.070 |
Why?
|
| Membrane Potentials | 1 | 2006 | 81 | 0.070 |
Why?
|
| Muscle Proteins | 1 | 2006 | 59 | 0.070 |
Why?
|
| Chromatography, Liquid | 1 | 2004 | 43 | 0.060 |
Why?
|
| Africa | 1 | 2004 | 27 | 0.060 |
Why?
|
| Medically Underserved Area | 1 | 2004 | 23 | 0.060 |
Why?
|
| Sequence Alignment | 1 | 2004 | 60 | 0.060 |
Why?
|
| Information Storage and Retrieval | 1 | 2004 | 22 | 0.060 |
Why?
|
| Cost of Illness | 1 | 2004 | 70 | 0.060 |
Why?
|
| User-Computer Interface | 1 | 2004 | 51 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 137 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2004 | 118 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2007 | 682 | 0.050 |
Why?
|
| Rats | 4 | 2008 | 1595 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2004 | 423 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2004 | 160 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 12 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2002 | 46 | 0.050 |
Why?
|
| Adipocytes | 1 | 2002 | 81 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2002 | 181 | 0.050 |
Why?
|
| Aluminum Hydroxide | 1 | 2020 | 1 | 0.050 |
Why?
|
| Vaccines, Subunit | 1 | 2020 | 4 | 0.050 |
Why?
|
| Neutralization Tests | 1 | 2020 | 12 | 0.050 |
Why?
|
| Vaccines, Attenuated | 1 | 2020 | 11 | 0.050 |
Why?
|
| Dengue Virus | 1 | 2020 | 4 | 0.050 |
Why?
|
| Vaccines, Synthetic | 1 | 2020 | 11 | 0.050 |
Why?
|
| Viral Envelope Proteins | 1 | 2020 | 10 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 19 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2020 | 55 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2002 | 495 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2020 | 525 | 0.040 |
Why?
|
| Adolescent | 2 | 2021 | 3539 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2018 | 33 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2010 | 285 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2010 | 359 | 0.040 |
Why?
|
| Prevalence | 1 | 2021 | 981 | 0.040 |
Why?
|
| Peptide Fragments | 2 | 2010 | 399 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2007 | 220 | 0.030 |
Why?
|
| Mice | 3 | 2007 | 2484 | 0.030 |
Why?
|
| Time Factors | 2 | 2012 | 2149 | 0.030 |
Why?
|
| Ecosystem | 1 | 2013 | 6 | 0.030 |
Why?
|
| Patient Admission | 1 | 2012 | 60 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2012 | 198 | 0.020 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2010 | 2 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2010 | 45 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 93 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 877 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 463 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2010 | 305 | 0.020 |
Why?
|
| Incidence | 1 | 2012 | 1199 | 0.020 |
Why?
|
| Isoindoles | 1 | 2008 | 6 | 0.020 |
Why?
|
| Quinuclidines | 1 | 2008 | 3 | 0.020 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2008 | 10 | 0.020 |
Why?
|
| Capsaicin | 1 | 2008 | 24 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2008 | 79 | 0.020 |
Why?
|
| Radio Waves | 1 | 2008 | 8 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2008 | 92 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2008 | 80 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2008 | 155 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 2006 | 2 | 0.020 |
Why?
|
| Multigene Family | 1 | 2007 | 51 | 0.020 |
Why?
|
| Taurine | 1 | 2006 | 6 | 0.020 |
Why?
|
| Muramidase | 1 | 2006 | 8 | 0.020 |
Why?
|
| Protons | 1 | 2006 | 23 | 0.020 |
Why?
|
| Solutions | 1 | 2006 | 36 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2008 | 175 | 0.020 |
Why?
|
| Cattle | 1 | 2006 | 103 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 94 | 0.020 |
Why?
|
| omega-Conotoxin GVIA | 1 | 2006 | 5 | 0.020 |
Why?
|
| Tetrodotoxin | 1 | 2006 | 11 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2006 | 70 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2006 | 48 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2007 | 244 | 0.020 |
Why?
|
| Kinetics | 1 | 2006 | 209 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2006 | 104 | 0.020 |
Why?
|
| Genotype | 1 | 2007 | 733 | 0.020 |
Why?
|
| Cell Line | 1 | 2006 | 435 | 0.020 |
Why?
|
| Programming Languages | 1 | 2004 | 4 | 0.020 |
Why?
|
| Systems Integration | 1 | 2004 | 11 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2004 | 37 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2004 | 125 | 0.010 |
Why?
|
| Documentation | 1 | 2004 | 46 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2008 | 845 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 582 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 2002 | 4 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 14 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 38 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2002 | 15 | 0.010 |
Why?
|
| Thiazoles | 1 | 2002 | 27 | 0.010 |
Why?
|
| beta Catenin | 1 | 2002 | 37 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2002 | 160 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 263 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2002 | 105 | 0.010 |
Why?
|
| RNA | 1 | 2002 | 92 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 289 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2002 | 508 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 632 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2002 | 833 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2002 | 469 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 767 | 0.010 |
Why?
|